This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange
Faron Pharmaceuticals Oy () has applied to have its shares listed on the Nasdaq First North Growth Market.
This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange.
Pending the application approval, the stock will begin trading on December 1.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE